Musculoskeletal diseases Flashcards
Select the statement that BEST describes myasthenia gravis.
a. pregnancy reduces the severity of the symptoms
b. neonates of affected mothers are at risk for muscle weakness
c. Edrophonium impairs muscle strength during symptom exacerbation
d. Acetylcholine production is decreased
B. neonates of affected mothers are at risk for muscle weakness
Myasthenia gravis is an
autoimmune disease in which IgG antibodies destroy post-junctional nicotinic receptors at the neuromuscular junction leading to skeletal muscle weakness
Signs and symptoms of myasthenia gravis includes
ptosis, dysphagia, dysarthria, and proximal muscle weakness
The first line medical treatment for myasthenia gravis is
oral pyridostigmine
Overdose of anticholinesterases leads to
cholinergic crisis and muscle weaknesis
______________ will help you determine if weakness is due to cholinergic crisis or myasthenic crisis.
Tensilon test
The ______ plays a key role for patients with myasthenia gravis, and ___________ brings symptom relief to many paitents.
thymus gland; thymectomy
A key feature of myasthenia gravis is
skeletal muscle weakness that becomes worse later in the day or that develops with exercise; periods of rest allow for the recovery of skeletal muscle function
Situations that exacerbate myasthenia gravis include
pregnancy
infection
electrolytes abnormalities
surgical and psychological stress
aminoglycoside antibiotics
How does myasthenia gravis affect neonates of mother’s with the condition?
anti-AchR IgG antibodies cross the placenta and cause weakness in 15-20% of neonates
this can persist up to 2-4 weeks
Treatment for myasthenia gravis includes
anticholinesterases
immunosuppression
plasmapheresis
surgery (thymectomy)
The patient with myasthenia gravis will be (select 2):
a. sensitive to vecuronium
b. resistant to rocuronium
c. sensitive to succinylcholine
d. resistant to succinylcholine
a. sensitive to vecuronium
d. resistant to succinylcholine
Patients with myasthenia gravis have ________ receptors at the neuromuscular junction.
fewer nicotinic receptors
Patients with myasthenia gravis have _________ to nondepolarizing NMBs.
increased sensitivity
Patients with myasthenia gravis have _______ to depolarizing NMBs.
increased resistance or decreased sensitivity
If a neuromuscular blocker is used for patients with myasthenia gravis, there is an increased risk of
residual neuromuscular blockade
Bulbar muscle weakness (mouth and throat) manifests as
difficulty handling oral secretions; this increases the risk of pulmonary aspiration